Survival Rates With Abiomed's Impella Heart Pump Evaluated in Japanese Registry
July 30, 2020—Abiomed announced that a 3-year, investigator-led, prospective study of Japanese patients who received an Impella heart pump showed that use of the device is associated with a 77% survival rate at 30 days in acute myocardial infarction (AMI) cardiogenic shock patients.
Study Evaluates Association of Readmissions After NSTEMI and Index Coronary Revascularizations
July 20, 2020—A study of the rate, causes, and predictors of 90‐day readmissions and the association with index hospitalization coronary revascularization after non–ST-segment elevation myocardial infarction (NSTEMI) in the United States was published by Jayakumar Sreenivasan, MD, et al online ahead of print in Catheterization & Cardiovascular Interventions.
Canon Medical Introduces New Configuration of Aquilion One/Genesis Edition Cardiac CT Solution
July 17, 2020—Canon Medical Systems USA, Inc. announced the introduction of a new configuration of the Aquilion One/Genesis Edition, an artificial intelligence–powered wide-area CT system for structural and coronary imaging.
One-Year Follow-Up Completed in PIONEER-III Trial of Sinomed’s Buma Supreme DES
July 13, 2020—Sino Medical Science Technology Inc. (Sinomed), a Tianjin, China–based developer of neuro- and cardiovascular technologies, announced the completion of 1-year follow-up in the randomized global PIONEER-III trial evaluating the Buma Supreme coronary drug-eluting stent (DES).
Acist Launches Navvus II Rapid Exchange FFR Microcatheter
July 9, 2020—Acist Medical Systems, Inc., a Bracco Group Company, announced the global launch of the Navvus II rapid exchange fractional flow reserve (FFR) microcatheter, a second-generation device for use with the company's RXi rapid exchange FFR system in percutaneous coronary intervention (PCI) procedures.
Study Examines Racial Disparities in PCI Outcomes
July 6, 2020—The American College of Cardiology (ACC) announced the publication of a study showing that Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major adverse outcomes, including death, compared with White patients.
SMT’s Supraflex Cruz Heart Stent Approved for National Reimbursement in France
June 24, 2020—Sahajanand Medical Technologies Pvt Ltd. (SMT), based in Mumbai, India, announced it has received the full reimbursement confirmation for its Supraflex and Supraflex Cruz coronary heart stents from the Ministry of Health and Public Affairs of France.
Puzzle Medical Devices Receives Financing for Development of Transcatheter Heart Pump
June 15, 2020—Puzzle Medical Devices Inc. announced the closure of a financing round that will support the continued development of the company’s long-term hemodynamic transcatheter heart pump intended for chronic support.
CE Mark Approved for 1-Month DAPT Indication for High Bleeding Risk Patients Treated With Medtronic’s Resolute Onyx DES
June 5, 2020—Medtronic announced it has received European CE Mark approval for a 1-month dual antiplatelet therapy (DAPT) indication for high bleeding risk (HBR) patients implanted with the Resolute Onyx drug-eluting stent (DES).
Teleflex Commences Enrollment in CTO-PCI IDE Study
June 2, 2020—Teleflex Incorporated announced the first patient enrollment in a clinical study that will evaluate the performance of Teleflex coronary guidewires and specialty catheters in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) procedures, which is currently an investigational indication for these products.
FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients With Right Heart Failure
June 1, 2020—Abiomed announced that the FDA has issued an emergency use authorization (EUA) for the company’s Impella RP to include patients with COVID-19–related right heart failure or decompensation, including pulmonary embolism (PE).
Massive Pulmonary Embolism: The Role of Mechanical Circulatory Support
Use of mechanical circulatory support appears to be feasible in a subset of patients with pulmonary embolism, but expertise in placement and postprocedural management is critical.
By Catalin Toma, MD; Michael Jolly, MD; and Christopher Huff, MD
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in Europe.